| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 2.2K | 30.9% | 57.4% |
| Total Income | 2.2K | 30.4% | 57.0% |
| Expenditure | 2.0K | 43.8% | 69.0% |
| PBT | 152.22 | 48.7% | 30.4% |
| Net Profit | 126.78 | 51.0% | 34.3% |
| OPM | 14.70% | 9.79pp | 7.83pp |
| NPM | 5.83% | 9.67pp | 8.11pp |
| EPS | 6.30 | 50.4% | 33.7% |
Narayana Hrudayalaya Reports Highest-Ever Revenue in Q3 FY26, Completes UK Acquisition
13 Feb 2026 · 13 Feb, 9:35 pm
Summary
Narayana Hrudayalaya Ltd, a leading healthcare service provider, announced its financial results for the third quarter (Q3 FY26) ended December 31, 2025. The company reported a consolidated operating revenue of INR 21,512 Mn, representing a YoY growth of 61.2%. The company's India revenue was INR 11,796 Mn, Cayman revenue was INR 4,991 Mn, and UK revenue was INR 4,902 Mn. The company's net debt to equity ratio was 0.53.
Key Highlights
- 1
Q3 FY26 Consolidated operating revenue at INR 21,512 Mn (YoY growth of 61.2%)
- 2
Adj. EBITDA of INR 4,662 Mn (YoY growth of 19.9%)
- 3
India Revenue INR 11,796 Mn (YoY growth of 11.8%)
- 4
Cayman Revenue INR 4,991 Mn (YoY growth of 70.0%)
- 5
UK Revenue INR 4,902 Mn (QoQ growth of N/A, as UK revenue is considered from 6th November 2025)
- 6
Consolidated Adj. EBITDA margin at 21.7%
- 7
Adj. PAT INR 2,548 Mn (YoY growth of 31.6%)
- 8
Adj. PAT margin at 11.8%
- 9
Total Borrowings less Cash & Bank Balance and Investments INR 22,321 Mn, representing a net debt to equity ratio of 0.53
- 10
Narayana Institute of Cardiac Sciences, Bangalore has performed 244 robotic cardiac surgeries (35% increase QoQ) and 48 TAVIs (50% increase YoY)
Management Comments
Dr. Emmanuel Rupert
After a strong second quarter, we are pleased to report the highest-ever revenue at the Group level in the third quarter. During the quarter, the Company completed the acquisition of Practice Plus Group Hospitals in UK, with effect from 6° November 2025. The acquisition aligns with the Company’s strategy to expand its international footprint and establish its presence in the UK market. India continues to perform well on account of steady footfall and higher realizations due to payor mix optimization and improved usage of technology across both clinical and non- clinical platforms. Our hospital business in Cayman continues to deliver robust performance, with the Insurance business showing steady growth, resulting in record revenues for the region. We are confident that the synergies between the hospital and insurance businesses will deliver steady growth going forward in the Cayman region. The domestic Integrated Care business continues to be on a strong growth path, and after a steady start, our domestic Insurance business has shown strong momentum this quarter, which we expect to build on going forward. We thank the investor community for their faith in us and remain confident of delivering on expectations for the year.
Informational and educational content only. Not investment advice.